Spotlight
Partners
- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Poll shows widespread support for access to experimental drugs
Public support exists for access to experimental drugs
Nine out of 10 people participating in an on-line U.S. Court of Appeals for the District of Columbia when it ruled in August that terminally ill patients have "no right" to access experimental drugs. Only 1% believe more liberal access to drugs under study would increase costs and liability for pharmaceutical companies, and 2% said they were not sure how to vote on the issue.
Click here to see more articles from Drug Topics Daily News.
To go to the Drug Topics homepage, click here.
Related Videos
Related Content
